Income Statement

Currency: KRW

	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	16	25	306	702	1 109	1 540	1 489
Revenue	3 923 N/A	5 015 +28%	5 967 +19%	4 588 -23%	3 922 -15%	3 825 -2%	4 258 +11%
Gross Profit
Cost of Revenue	(1 903)	(2 408)	(2 849)	(2 029)	(1 596)	(2 377)	(2 502)
Gross Profit	2 019 N/A	2 608 +29%	3 117 +20%	2 559 -18%	2 326 -9%	1 448 -38%	1 756 +21%
Operating Income
Operating Expenses	(7 729)	(11 547)	(15 316)	(15 937)	(15 467)	(15 318)	(15 046)
Selling, General & Administrative	(5 605)	(8 521)	(11 183)	(11 657)	(11 024)	(10 576)	(10 430)
Research & Development	(1 208)	(1 671)	(2 320)	(2 504)	(2 594)	(2 861)	(2 811)
Depreciation & Amortization	(917)	(1 355)	(1 813)	(1 776)	(1 850)	(1 880)	(1 806)
Operating Income	(5 710) N/A	(8 940) -57%	(12 199) -36%	(13 378) -10%	(13 142) +2%	(13 870) -6%	(13 291) +4%
Pre-Tax Income
Interest Income Expense	291	678	79	5 947	5 242	(8 828)	(8 473)
Gain/Loss on Disposition of Assets	0	0	(6)	(123)	(123)	0	0
Total Other Income	6	10	(179)	(441)	(830)	(1 672)	(1 598)
Pre-Tax Income	(5 412) N/A	(8 250) -52%	(12 305) -49%	(7 996) +35%	(8 853) -11%	(24 370) -175%	(23 362) +4%
Net Income
Tax Provision	133	(104)	(68)	(94)	(197)	134	114
Income from Continuing Operations	(5 279)	(8 354)	(12 373)	(8 089)	(9 050)	(24 236)	(23 247)
Income to Minority Interest	0	1	1	0	0	0	0
Net Income (Common)	(5 278) N/A	(8 353) -58%	(12 372) -48%	(8 089) +35%	(9 049) -12%	(24 236) -168%	(23 247) +4%
EPS (Diluted)	-328.97 N/A	-519.91 -58%	-769.7 -48%	-503.42 +35%	-560.8 -11%	-1 500.39 -168%	-1 396.58 +7%

Curiox BioSystems Co Ltd
KOSDAQ:445680